PP
RPTP

Paloma Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Paloma Partners’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,881
Closed -$102K – 1468
2013
Q2 		$102K Buy
+10,881
New +$73.7K 0.01% 1063

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Paloma Partners's RPTP Position: Q3 2013 in Review

Paloma Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2013, closing a stake of 10,881 shares — an estimated $102K sold.

Paloma Partners first reported a position in RPTP in Q2 2013 and held it in 1 quarter. The position peaked at $102K in Q2 2013. 71 funds tracked by Wall St. Rank hold RPTP as of Q3 2013.

  • Paloma Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • Paloma Partners sold 10,881 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2013, an estimated $102K.
  • Paloma Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • Paloma Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $102K in Q2 2013.
  • 71 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2013.

Based on Paloma Partners's 13F filing for Q3 2013, filed 14 Nov 2013.